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Abstract
The applications of functional genomics, proteomics and informatics to cancer research
have yielded a tremendous amount of information, which is growing all the time. Much
of this information is available publicly on the Internet and ranges from general
information about different cancers from a patient or clinical viewpoint, through to
databases suitable for cancer researchers of all backgrounds, to very speciﬁc
sites dedicated to individual genes or molecules. A simple search for ‘cancer’ from a
typical Web browser search engine yields more than half a million hits; an even more
speciﬁc search for ‘leukaemia’ (>40 000 hits) or ‘p53’ (>5700 hits) yields far too
many hits to allow one to identify particular sites of interest. This review aims to provide a
brief guide to some of the resources and databases that can be used as springboards to
home in rapidly on information relevant to many ﬁelds of cancer research. As such,
this article will not focus on a single website but hopes to illustrate some of the ways that
postgenomic biology is revolutionizing cancer research. It will cover genomics
and proteomics approaches that have been applied to studying global expression
patterns in cancers, in addition to providing links ranging from general information
about cancer to speciﬁc cancer gene mutation databases. Copyright # 2001 John Wiley &
Sons, Ltd.
A starting point for new cancer
researchers
There is a good general introduction to cancer
biology at the National Centre for Biotechnology
Information (NCBI) Genes and Disease site (http://
www.ncbi.nlm.nih.gov/disease/Cancer.html). This site
has links to several common cancers and cancer
genes which contain concise summaries of the
disease, its impact and what is known about the
underlying genetics. Each description is exempliﬁed
by one or two genes known to be important in that
disease, e.g. the colon cancer entry describes the
roles of the mismatch repair genes MSH2, MSH6
and MLH1. Links to OMIM, LocusLink and
EntrezGenome databases (see below) are included
to access further information about these genes.
OncoLink (http://oncolink.upenn.edu) from the
University of Pennsylvania Cancer Centre is an
excellent source of news and literature information
about cancer. The ‘Disease menus’ link leads to
speciﬁc sets of information about each cancer,
generally from a more clinical viewpoint. The
whole site can also be searched for individual or
combined terms, or just the Cancer News section,
which again focuses on clinical studies more than
basic research. There are also links to FAQs,
clinical trial information, information for patients,
book reviews and more.
Cancer genes and genetics
There are many ways to focus in rapidly on general
and cancer-related information about an individual
gene using the resources at the NCBI—an impres-
sively curated, comprehensively integrated set of
resources that allow a rapid and thorough trawl of
gene-related data. All of these resources can be
queried using a gene name (e.g. b-catenin), gene
symbol (CTNNB1), accession number, or more
general query term (e.g. catenin). All resources are
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where appropriate. The oncogene b-catenin has
been used as an example query term for the
following summaries.
Online Mendelian inheritance in man (OMIM)
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=
OMIM
The OMIM resource is a catalogue of genes and
genetic disorders and contains locus information
with a detailed review of the literature relevant to
the queried gene and its genetic characterization
(e.g. b-catenin, entry 116806). These reviews can be
quite comprehensive and are kept well up to date.
References are linked to PubMed and internally
linked to other OMIM entries where appropriate.
Selected allelic variations, in particular disease
associated mutations culled from the literature, are
detailed with links to the relevant literature.
Genes and loci in the vicinity of the queried term
(e.g. 3p22–p21.3) can be viewed in the OMIM Gene
Map tables, organized by chromosomal location
and listing gene name and symbol and links to the
map viewer. Any disorders associated with the
entries are indicated (e.g. for b-catenin: colorectal
cancer; hepatoblastoma; pilomatricoma; ovarian
carcinoma, endometrioid type) and the gene
mapping methods used to deﬁne that locus are
supplied. The OMIM Morbid Map can also be
queried by disease term to ﬂag all genes curated as
being involved in that disease.
UniGene
http://www.ncbi.nlm.nih.gov/UniGene/
UniGene attempts to cluster EST and cDNA
sequences corresponding to a gene in an automated
manner. For a given search term, UniGene returns
a comprehensive entry for the cluster (e.g. b-catenin
Hs. 171271) listing all constituent ESTs, with brief
descriptions of library source and sequence read
(e.g. 3k sequence, including poly A tail, etc.). The
UniGene entry also links to gene and complete
mRNA sequences and includes a selected list of
homologues, ranked by identity at the protein level
(with links to database entries). It also supplies
cytogenetic information (with a link to a close-up of
the chromosomal region via OMIM) and expression
information, deﬁned by the cDNA library source of
each of the clustered ESTs, in addition to links to
SAGE data (see below). One drawback of this
automated system that should be noted is that it
can lead to some false clustering, due to partial or
incomplete cDNA sequence data.
LocusLink
http://www.ncbi.nlm.nih.gov/LocusLink/
LocusLink provides a curated information
resource centred around the queried genetic locus
(e.g. b-catenin entry, 1499). It collates a tremendous
amount of useful information, such as literature
aliases, phenotype descriptions, chromosomal map-
ping information and context and STS markers in
the genomic region. Protein sequence domains are
listed (such as armadillo/b-catenin-like repeats) and
are linked to the CD-Browser entry (e.g. ARM).
This entry lists all proteins with this domain that
can be individually or collectively selected and
aligned from the site. Alternatively, complete
protein or nucleotide sequence links can be
BLASTed directly from the site.
GeneCard
http://bioinformatics.weizmann.ac.il/cards/
GeneCard is a database of human genes and
products collating information from a variety of
different resources, provided by the Weizmann
Institute, Israel. GeneCard links back to nucleotide
and protein sequences, UniGene, OMIM, mamma-
lian homologues and cytogenetic location.
Tumour Gene Database (TGD)
http://condor.bcm.tmc.edu/oncogene.html/
The Tumour Gene Database aims to provide
collections of facts (culled from literature reports)
about gene entries. This site can be searched by
gene name, or by fact term—e.g. if you are looking
for facts involving cisplatin. The database is not
very comprehensive, but there is a wealth of
information on some genes (e.g. BRCA1), and if
your gene of interest is present, then TGD is an
excellent resource for literature searching with
concise descriptions of the relevant fact from a
particular paper. Facts are returned grouped under
avariety of headings,e.g. cell cycle, clinical, function,
phenotype, reviews,tumour incidence,andare linked
to the PubMed entry of the reference paper.
Individual gene mutation databases
There are many databases that catalogue mutations
identiﬁed in common oncogenes or tumour
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nfdht.nl/database/msh2.htm). LocusLink and Gene-
Card entries (see above) commonly include links to
individual gene mutation databases, where avail-
able. There is also a list of many gene mutation
databases at the Human Gene Mutation Database
(http://archive.uwcm.ac.uk/uwcm/mg/docs/oth_mut.
html).
Cancer genomics
The Cancer Genome Anatomy Project
(CGAP)
The stated aim of CGAP (www.ncbi.nlm.nih.gov/
ncicgap) at the National Cancer Institute is to deﬁne
the molecular anatomy of a cancer cell, in particular
to deﬁne which genes are expressed in cancers. This
information has been obtained from the sequencing
of cDNA libraries derived from different cancer and
normal samples. The site is divided into ﬁve
sections: the human Tumor Gene Index; the mouse
Tumor Gene Index; the Molecular Proﬁling Initia-
tive; the Genetic Annotation Initiative; and the
Cancer Chromosome Aberration Project (Figure 1).
The human and mouse Tumour Gene Indexes
include the cDNA sequence databases generated
from an impressive range and number of tumour
and normal tissue and cell libraries. The resource is
intended to identify which genes are expressed in
different tumours and to allow the identiﬁcation of
novel genes. The cDNA libraries used can be
searched or browsed and are well documented for
numbers of clones sequenced per library, source
and preparation method of library, normalization
method (if used) and purchasing details. The cDNA
libraries can be searched using the GeneExpress
tool for a particular gene by UniGene cluster ID
(see above). All cDNA libraries found to contain
this sequence are returned, with the abundance of
the sequence indicated (e.g. three copies in 15 000
sequences), although the libraries are not ranked in
any discernible order, such as tissue type or
sequence abundance. The site has two tools for
comparing sequence expression proﬁles between
libraries: Digital Differential Display and cDNA
Xproﬁler. However, the cDNA library sequencing
approach for comparing gene expression patterns is
quite limited, for two main reasons. First, many of
the libraries used have been normalized, and thus
have distorted transcript abundance levels. Second,
the depth of sequencing of each library is generally
limited, leading to skewed relative abundances of
constituent sequences. This renders much of the
comparative expression analysis of limited value.
The Molecular Proﬁling Initiative aims to provide
a resource for collating the technical requirements
for analysis of cancer and tissue specimens;
however, there is currently no data in this branch
of the site. The Genetic Annotation Initiative (GAI)
aims to identify variation (SNPs) in genes impor-
tant in cancer. The GAI utilizes data-mining tools
to identify candidate variation from public sequence
databases, which are then experimentally analysed
to determine whether this variation is genuine or a
sequencing artefact. This approach is currently in
early stages and is inherently limited by the input
EST data available and depth of coverage problem.
The GAI will undoubtedly be overshadowed by the
much more ambitious and thorough approaches
proposed by Professor Mike Stratton, joint head of
the Cancer Genome Project. This project (see http://
www.sanger.ac.uk/Info/Press/991020.shtml for press
release), established by the Wellcome Trust and to
be sited at the Sanger Centre, aims to build on the
Human Genome Project data to identify every gene
mutated in cancer, and will without doubt become a
central resource for the cancer community in
the future.
The Cancer Chromosome Aberration Project has
compiled a database of the chromosomal aberra-
tions found in different cancers. This database
can be searched by the Recurrent Chromosome
Aberrations link and this search can be optionally
restricted by chromosome, arm, band, tissue type
and/or neoplasm. For example, a search for ‘Wilms’
tumour’ reveals a table of the recurrent abnorma-
lities observed in Wilms’ tumour patients, indicating
band, abnormality, neoplasm and number of cases
in the database. In this example (Figure 2) many
cases involve deletions of the 11p11–14 region.
These links can be followed to the locus map of
this region in OMIM, where it can be seen that
the Wilms’ tumour susceptibility genes WT1 and
WT2 reside.
Mouse Tumor Biology Database (MTB)
http://tumor.informatics.jax.org/FMPro?-db=
TumorInstance&-format=mtdp.html&-view
This Jackson Laboratory site was reviewed in
Issue 2 of this journal (Wixon, 2000), so I will just
mention it brieﬂy here. MTB (Bult et al., 2000) is
searchable by tumour type, tissue/organ, literature
reference, gene or genetic alteration to link to an
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tumours. This is an excellent resource to investigate
mouse models and homologues of your gene
of interest.
Transcriptomics
There are resources on the Internet for at least
three approaches to gene expression proﬁling
(transcriptomics) in tumours: cDNA library
sequencing; Serial Analysis of Gene Expression
(SAGE); and microarray analysis.
The approach of mass sequencing of cDNA
libraries has been extensively used by CGAP,
as described above. The principal limitation of
this approach is that the depth of coverage required
to get statistical sampling of expression levels is very
high, and that many cDNA library preparations are
generated by normalization, which, by deﬁnition,
alters the relative abundance of constituent
sequences. These limitations can be partially resolved
by use of the SAGE technique (see below), which can
readily generate the greater depths of coverage
required for meaningful differential analysis.
Serial Analysis of Gene Expression (SAGE)
The SAGE technique, developed by Bert Vogelstein,
Kenneth Kinzler and colleagues at Johns Hopkins
University (Velculescu et al., 1995), generates
Figure 1. The Cancer Genome Anatomy Project home page. The links to the ﬁve constituent Initiatives can be followed
from the top bar, the side bar, or the main panel. The CGAP How To... link at the top of the side bar gives useful pointers for
getting the most out of the CGAP site. Reproduced with the kind permission of the National Library of Medicine http://
www.ncbi.nlm.nih.gov
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mRNA samples from the mass sequencing of 9–10
base
tags corresponding to 3k regions of transcripts
(see www.ncbi.nlm.nih.gov/SAGE and http://www.
SAGEnet.org for detailed descriptions of the
technique and its drawbacks). The technique has
advantages over microarray approaches as it
surveys unknown transcripts without the need to
isolate a physical clone, although the allocation of
tags to genes can be imprecise in some cases.
A considerable depth of coverage of tens of
thousands of tags can readily be generated, a
considerable improvement over the EST sequencing
approaches of CGAP for comparative analysis of
expression levels of genes in different samples.
A large number of SAGE analyses have been
performed on >80 different cancer cell lines, with
an average coverage of 50 000 tags per library.
Two example differential analyses, of colon and
brain tumour against normal tissue, are presented
at www.ncbi.nlm.nih.gov/SAGE. Following these
links takes you to the comparison and analysis
page for these experiments (Figure 3), where the
relative abundance levels of the indicated tags and
conﬁdence limits are given. Links to the SAGE
libraries provide details of library preparation,
numbers of tags and corresponding genes, etc. The
Figure 2. The Cancer Chromosome Aberration Project. The Recurrent Chromosome Aberrations page was searched by
‘neoplasm’ type for ‘Wilms’ tumour’. The table shows some of the recurrent aberrations identiﬁed in cases of Wilms’
tumour, organized by chromosome band affected. Note the predominance of deletions involving the 11p11–p14 region
corresponding to loss of the WT1 and/or WT2 tumour suppresser loci. Reproduced with the kind permission of the
National Library of Medicine http://www.ncbi.nlm.nih.gov
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libraries can be analysed from a ‘Virtual Northern’
button, which identiﬁes potential SAGE tags from a
given sequence, which must include the 3k terminal
sequence of the transcript. These tags can then be
followed to show abundance levels in different
SAGE libraries, UniGene clusters and links to the
SAGE libraries themselves. While all possible tags
are indicated, in general only one of these is
likely to be generated from the SAGE technique
(generally the tag nearest the 3k terminal end of the
gene). Any of the SAGE libraries available at NCBI
can be compared using the SAGEmap Xproﬁler
tool individually, or as pooled groups—the two
colontumoursamplesandtwo normal colonsamples
in Figure 3 have been analysed in this manner, but
more than two samples can be compared.
Microarray analysis
Microarray analysis does not suffer from the
limitations of depth of sample coverage that
Figure 3. Serial Analysis of Gene Expression (SAGE) colon cancer vs. normal colon comparison. The constituent SAGE
libraries in each of the comparator groups A and B are shown, with links to associated library information. The ﬁrst three
tags (of many) are shown in the results table. Clicking on the SAGE tag reveals the abundance of that tag in all the different
SAGE libraries available via the NCBI. The ﬁrst tag, corresponding to UniGene Hs. 1650 ‘downregulated in adenoma’ DRA
gene, was sequenced seven times in the group A libraries and 105 times in the group B libraries. The A:B column shows that
all of these three tags are more abundant in the normal colon epithelium libraries (group B) and allows rapid identiﬁcation of
tags that are up- or downregulated in the different libraries. Reproduced with the kind permission of the National Library of
Medicine http://www.ncbi.nlm.nih.gov
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extent SAGE, and can be considered the technique
that is the most likely to determine representative
expression levels of given genes. However, the
limitation of microarray analysis is that it is only
possible to detect a sequence that is included on the
array, and whole human genome arrays are not yet
practicable, although they may become so in the
next few years with the completion of the Human
Genome Project and the increased miniaturization
capability of array technology.
The laboratory of Patrick Brown at Stanford
University is one of the leaders in the ﬁeld of cDNA
microarray analysis of cancer. The Stanford Micro-
array Database (http://genome-www4.stanford.edu/
MicroArray/SMD/) has links to some of the land-
mark papers in the ﬁeld of microarray analysis of
cancer (Alizadeh et al., 2000; Ross et al., 2000),
including the large-scale NCI analysis of 60 cancer
cell lines and drug sensitivities (Scherf et al., 2000;
see also http://discover.nci.nih.gov/nature2000/).
These huge datasets can be browsed or searched to
track expression changes in genes represented on
their microarrays across up to 60 common cancer
cell lines. The individual databases for each of their
key publications can also be browsed or searched
individually, using the GeneXplorer web server to
track expression levels of individual genes across
the complete datasets. The site also has links to
other microarray sites, and to the Stanford Geno-
mics Resource for genomics information for a
variety of model organisms.
Proteomics
The application of proteomics technology to the
study of cancer is another burgeoning area
of interest. Several groups have begun to generate
and collate proteomics databases on the web
(e.g. Ludwig Institute http://www.ludwig.ucl.ac.uk/
st/elec.html, and the NCI protein expression data-
base (http://www.nci.nih.gov/intra/lmp/jnw/Prot.html;
Myers et al., 1997) and there are indexes of these
resources (available at http://expasy.cbr.nrc.ca/ch2d/
2d-index.html and http://www-lecb.ncifcrf.gov/ips-
databases.html).
I shall focus on one resource in particular, the
bladder cancer database from the laboratory of
Julio Celis at the Danish Centre for Human
Genome Research in Aarhus (http://biobase.dk/
cgi-bin/celis). This site includes an excellent
introduction to bladder cancer pathology and
aetiology and describes their research interests and
experimental considerations of proteomics in cancer
research. The site also includes movie and text
protocols for sample preparation and running 2D
gels. The other principal interest of this group is
keratinocyte biology, which is in fact currently
covered in more detail than bladder cancer.
The bulk of the site is dedicated to the 2D PAGE
Databases and Galleries (Celis et al., 1998). The
Human 2D PAGE Databases link summarizes the
gel data obtained from different keratinocyte or
bladder cancer samples, with links to a representa-
tive gel image for each cell or sample type
(Figure 4). Spots that have been identiﬁed are
marked with red crosses, and are linked to
summary information for that protein, which
includes a brief description of the protein with size
and pI values, a list of the tissues/samples expres-
sing this protein, method of identiﬁcation and links
to other database entries, including SWISS-PROT,
UniGene and OMIM, if available. Spots that are
not marked have not yet been identiﬁed and
clicking on them links to a spot identiﬁcation
number, the approximate size and pI, and expres-
sion information. Gel databases can also be inter-
rogated to search for your favourite protein or
keyword, or browsed by protein name. There is also
a Mouse 2D PAGE Database, which is currently
more limited but includes links to mouse genome
and transgenic databases. There are multiple
normal mouse tissue samples in the ZOO 2D
Gel Gallery.
The Human 2D Gel Gallery links for human
and mouse lead to a wide range of tissue/cell
or organelle sample images and some side-by-side
comparisons. These comparisons have some
differences indicated (Figure 5), which are linked
to the protein description database, although spots
that are not marked cannot be followed from this
comparison view.
A wide range of antibodies have been used to
probe different cell line samples, and these images
can be viewed from the 2D Gel Immunoblots link,
sorted by antibody description. The corresponding
protein spots indicated are also linked to the
protein database.
Other links to cancer resources on the
web
There are a number of sites that have collated
indexes of links to more cancer sites (such as
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of the sites I have discussed in this review also
include links to additional sites in their ﬁelds
of interest. Of particular interest is http://tumor.
informatics.jax.org/cancer_links.html—a compre-
hensive set of links to cancer resources on the web
from the Jackson Laboratory, Maine, USA (see
also Bult et al., 1999). Links are grouped by: animal
models (descriptions of models and phenotypes as
well as sources for animals); cancer genetics and
genomics; cancer biology; pathology; reagents;
services; and protocols. An index of the research
resources available from the NCI, including ani-
mals, specimens, cell lines, etc., is given at http://
resresources.nci.nih.gov.
Discussion
It is clear that postgenomic biology has a tremen-
dous amount to offer to cancer research, and that
there are a host of resources available via the
Internet to access this information. The technology
is improving all the time and it is now becoming
possible to obtain a level of description of a cancer
cell undreamed of a few years ago. Some of
the latest techniques for proﬁling cancer cells at
the transcriptional, proteomic and molecular
pathway levels are reviewed in Liotta and Petricoin
(2000) and indicate the exciting potential for
making tremendous advances in cancer research
that will undoubtedly be fulﬁlled in the years to
come.
Figure 4. The Danish Centre for Genome Research Transitional Cell Carcinoma (TCC) 2D PAGE database. This image
shows the master template for a TCC 2D gel. In this view, all spots that have been identiﬁed and correspond to known
proteins are marked with a red cross, while unmarked spots correspond to unknown proteins. The database can be searched
or browsed by following the links in the top right of this image. Reproduced with kind permission of Julio E. Celis of The
Danish Centre for Genome Research http://biobase.dk/cgi-bin/celis
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of the resources available on the Internet that can
be used to facilitate cancer research in the post-
genomic era. There is a lot more information out
there, so start looking!
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Some of the sites reviewed will already be known to you but perhaps their content will be less well-known.
The Website Review is intended to help you discover new sites of interest, but also to provide a rapid and
convenient means of revealing what you always knew was there but never had the time or inclination to
look at. These articles are a personal critical analysis of the website. If you have any information about
sites you think are worthy of being more widely known, the Managing Editor would be pleased to hear
from you.
Website Review 43
Copyright # 2001 John Wiley & Sons, Ltd. Comp Funct Genom 2001; 2: 35–43.